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Abstract
Objective:  To  assess  the  relationship  between  the  degree  of  waist  circumference  (WC)  and  non-
alcoholic  fatty  liver  disease  (NAFLD)  in  obese  adolescents  of  both  genders,  analyzed  according
to quartiles  of  WC.
Methods:  Cross-sectional  study  that  involved  247  obese  adolescents  aged  12--19  years.  Mean
values of  the  nutritional  parameters  and  serum  analyses  were  compared  with  the  groups  using
the independent  t-test.  Pearson  correlation  coefﬁcient  was  used  to  determine  the  relationship
of the  parameters  studied.  Chi-square  test  for  trend  was  used  to  determine  the  relationship
between  the  prevalence  of  the  NAFLD  and  WC  quartile  by  gender.
Results: NAFLD  were  presented  in  60%  of  the  study  participants.  Obese  adolescents  in  the  3rd
and 4th  quartiles  of  WC  presented  higher  prevalence  of  NAFLD  when  compared  with  that  in
the 1st  quartile  in  both  genders.  The  NAFLD  patients  had  signiﬁcantly  higher  values  for  body
weight, BMI  (body  mass  index),  BAZ-score  (BMI-for-age  z-scores),  total  fat  (%  and  kg),  WC,
visceral fat,  insulin,  insulin  resistance  index  (HOMA-IR),  aspartate  aminotransferase  and  alanine
aminotransferase,  when  compared  with  non-NAFLD  obese  adolescents.
Conclusions:  In  conclusion,  the  results  presented  here  suggest  that  an  increase  in  WC  can  reli-
ably predict  the  risk  of  NAFLD  in  obese  adolescents.  This  is  a  low  cost  and  easy-to-use  tool  that
can help  in  screening  in  adolescents.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
 BY  license  (https://creativecommons.org/licenses/by/4.0/).access article  under  the  CC∗ Corresponding author.
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Circunferência  da  cintura  como  marcador  para  triagem  de  doenc¸a hepática  gordurosa
não  alcoólica  em  adolescentes  obesos
Resumo
Objetivo:  Avaliar  a  associac¸ão  entre  o  grau  de  circunferência  da  cintura  (CC)  e  doenc¸a  hepática
gordurosa  não  alcoólica  (DHGNA)  em  adolescentes  obesos  de  ambos  os  sexos,  avaliados  de
acordo com  quartis  de  CC.
Métodos:  Estudo  transversal  envolvendo  247  adolescentes  obesos  com  idades  entre  12  a  19
anos. Os  valores  médios  dos  parâmetros  nutricionais  e  analises  séricas  foram  comparados  com
os grupos  utilizando  o  teste  t  independente.  O  coeﬁciente  de  correlac¸ão  de  Pearson  foi  utilizado
para determinar  a  relac¸ão  entre  os  parâmetros  estudados.  O  teste  do  qui-quadrado  de  tendência
foi utilizado  para  determinar  a  relac¸ão  entre  a  prevalência  da  DHGNA  e  quartil  da  CC  por  sexo.
Resultados:  DHGNA  estava  presente  em  60%  dos  participantes  do  estudo.  Adolescentes  obesos
nos quartis  3  e  4  de  CC  apresentaram  maior  prevalência  de  DHGNA  quando  comparados  com
aqueles no  primeiro  quartil  em  ambos  os  sexos.  Os  pacientes  com  DHGNA  tinham  valores  signi-
ﬁcativamente  mais  elevados  de  peso  corporal,  IMC  (índice  de  massa  corporal),  IMC/I  (IMC  para
Idade) z-escore,  gordura  total  (%  e  kg),  CC,  gordura  visceral,  insulina,  índice  de  resistência  à
insulina (HOMA-IR),  aspartato  aminotransferase  e  alanina  aminotransferase,  quando  compara-
dos com  adolescentes  obesos  sem  DHGNA.
Conclusões:  Em  conclusão,  os  resultados  aqui  apresentados  sugerem  que  um  aumento  da  CC
pode prever  com  seguranc¸a o  risco  de  DHGNA  em  adolescentes  obesos.  Essa  é  uma  ferramenta
de baixo  custo  e  fácil  de  utilizar  que  pode  ajudar  na  triagem  de  adolescentes.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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onalcoholic  fatty  liver  disease  (NAFLD)  is  the  most  common
ause  of  chronic  liver  disease  worldwide  and  has  been  rec-
gnized  as  the  early  manifestation  of  obesity  and  metabolic
yndrome.1 NAFLD  is  characterized  by  the  accumulation  of
arge  droplets  of  triglycerides  within  hepatocytes  in  the
bsence  of  chronic  alcohol  consumption.2 Currently,  NAFLD
ffects  between  3%  and  11%  of  the  pediatric  population
eaching  the  rate  of  46%  among  overweight  and  obese  chil-
ren  and  adolescents.3 Indeed,  previous  study  from  our
roup  found  that  NAFLD  affected  52%  of  obese  adolescents.4
NAFLD  development  is  inﬂuenced  by  multiple  genetic  and
nvironmental  factors.  Currently,  NAFLD  is  recognized  as  the
epatic  component  of  metabolic  syndrome  due  to  its  strong
ssociation  with  obesity,  dyslipidemia,  hypertension  and
nsulin  resistance  index  (HOMA-IR).  It  has  long  been  known
hat  there  is  a  highly  signiﬁcant  relation  between  NAFLD  and
nsulin  resistance.  A  study  developed  with  Japanese  children
uggested  that  hyperinsulinemia  was  the  most  important
linical  manifestation  associated  with  NAFLD.5 Moreover,
nsulin  resistance  is  accepted  as  the  main  pathophysiologic
actor  in  developing  NAFLD.6
In  agreement,  de  Piano  et  al.7 veriﬁed  that  adolescents
ith  visceral  obesity  and  high  HOMA-IR  levels  presented  a
igher  risk  of  developing  NAFLD,  which  could  lead  to  the
ccumulation  of  lipid  in  the  hepatocytes.  In  addition,  it  was
emonstrated  that  each  1-cm  increase  in  visceral  adiposity
as  associated  with  a  two-fold  greater  risk  of  NAFLD  in  obese
dolescents.8
In  fact,  the  central  adiposity  is  associated  with
hronic  low-grade  inﬂammation,  which  accelerates  insulin
a
b
oesistance  and  accumulation  of  hepatocellular  fat.  Subjects
ith  NAFLD  are  at  risk  of  developing  cardiovascular  dis-
ase  (CVD)  through  insulin-resistance  related  mechanisms.9
herefore,  it  is  important  to  assess  visceral  adiposity  in  clin-
cal  practices.  For  assessment  of  central  obesity  in  young
ges,  ultrasound  and  magnetic  resonance  imaging  are  avail-
ble.  However,  these  procedures  have  some  limitations  for
road  use,  such  as  cost.  On  the  other  hand,  WC  may  be  a
imple  clinical  and  cost-effective  tool  to  be  used  as  a  sur-
ogate  marker  for  NAFLD.10 WC  has  been  shown  to  be  an
nexpensive  tool  for  assessing  central  obesity  in  the  clinical
ractice,  with  excellent  correlation  with  abdominal  imaging
nd  high  association  with  CVD  risk.11 For  this  reason,  WC  is
ne  of  the  diagnostic  criteria  proposed  by  the  International
iabetes  Federation  (IDF)  in  adolescents  and  has  been  iden-
iﬁed  as  a valuable  predictor  of  metabolic  syndrome  and  CVD
isk.12
The  relation  between  NAFLD  and  atherosclerosis  devel-
pment  has  been  evaluated  in  pediatric  studies.1,9 Fallo
t  al.13 reported  that  WC  was  a  predictor  for  NAFLD  in  their
tudy  that  included  86  hypertensive  obese  adults.  Another
tudy  found  that  the  increased  WC  and  body  mass  index  (BMI)
ere  associated  with  a  signiﬁcant  higher  risk  of  insulin  resis-
ance  and  NAFLD  in  healthy  Koreans  adults.  In  addition,  the
uthors  reinforced  the  importance  of  using  both  BMI  and  WC
n  clinical  practice,  because  they  may  be  helpful  in  eval-
ating  the  risk  of  NAFLD  and  insulin  resistance.14 Finally,
C  measurement  has  known  to  predict  cardiovascular  risk,
lthough  its  value  for  NAFLD  risk  in  adolescents  has  not  yet
een  explored.
Therefore,  WC  is  a  convenient  measure  of  abdominal
besity.  However,  few  studies  have  been  performed  on  the
Waist  circumference  as  a  marker  for  screening  NAFLD  in  obese  adolescents  49
Ethical
committee
0135/04
Pubertal evaluation
Girls: breast-stage 2
Boys: genitalia-stage 3
Clinical evaluation ECG
Z score ≥ +2SD 12 to 19 years Media
Clinical measurements
Serum analysis
Glucose
Insulin
AST
ALT
Anthropometric
Weight
Height
Body composition
BMI
Waist circumference
Ultrasound
Visceral fat
Subcutaneous fat
GEO
 GEO
d
s
o
p
b
g
w
p
d
h
m
w
F
P
T
c
m
o
t
i
t
w
e
w
w
s
b
I
f
a
PFigure  1  Description  of  study  ﬂow.  ECG,  electrocardiogram;
ALT, alanine  aminotransferase.
relationship  between  intra-abdominal  fat  area  and  NAFLD
risk.  Thus,  in  this  study  we  aimed  to  assess  the  relationship
between  the  WC  and  the  presence  of  NAFLD  in  Brazilian
obese  adolescents  of  both  genders,  analyzed  according  to
quartiles  of  WC.
Method
The  study  was  formally  approved  by  the  Committee  of
Ethics  in  Research  of  the  Universidade  Federal  de  São  Paulo
(UNIFESP;  protocol  no.  (#0135/04)  and  registered  as  a  clin-
ical  trial  (NCT01358773).  Written  informed  consent  was
obtained  from  all  potential  participants  and/or  their  par-
ents  or  legal  guardians  prior  to  the  commencement  of  the
study.
The  study  ﬂow  is  shown  in  Fig.  1.  For  this  cross-
sectional  study,  247  obese  adolescents  with  aged  from  12
to  19  years  were  included.  Data  were  collected  from  the
screening  obese  adolescents  in  the  years  2007--2010.  Obese
adolescents  were  recruited  from  Multidisciplinary  Obesity
Intervention  Program  outpatient  clinic  of  the  Federal  Uni-
versity  of  São  Paulo.  All  patients  enrolled  in  this  study  were
assessed  before  weight  loss  therapy.  Nutritional  status  was
calculated  according  to  height-for-age  Z-score  (HAZ)  and
BMI-for-age  values  using  WHO  Anthro-Plus  1.0.4  software.
The  nutritional  diagnosis  was  based  on  the  BMI-for-age  (BAZ)
for  the  children  aged  more  than  5  years  and  adolescents
≤19  years  of  age  (Z  score  ≥+2SD),  according  to  the  cut-
offs  deﬁned  by  World  Health  Organization.16 Non-inclusion
criteria  were  identiﬁed  as  genetic,  metabolic  or  endocrine
disease,  chronic  alcohol  consumption  (≥20g/day),  presence
of  viral  hepatic  diseases,  previous  drug  use,  and  other  causes
of  liver  steatosis.
Pubertal  stage  was  established  with  clinical  screening
and  anthropometric  measures  were  assessed  (stature,  body
mass,  BMI  and  body  composition).  Ultrasound  (US)  was
performed  and  blood  sample  was  collected  and  ana-
lyzed  for  metabolic  proﬁle.  To  exclude  inﬂuences  of
c
C
C
A,  Group  of  Study  in  Obesity;  AST,  aspartate  aminotransferase;
iurnal  variations,  the  procedures  were  scheduled  for  the
ame  time  of  the  day  for  all  subjects,  8:00AM  after  an
vernight  fasting.
All  adolescents  were  examined  by  a  trained  physician  and
ubertal  stage  was  classiﬁed  according  to  Tanner  scale15 for
oth  boys  and  girls.  Girls  with  breast-stage  2  and  boys  with
enitalia-stage  3  were  considered  pubertal,  whilst  those
ho  had  yet  to  attain  these  stages  were  classiﬁed  as  non-
ubertal.15 None  of  the  participants  presented  early  or
elayed  puberty,  although  levels  of  testosterone,  luteinizing
ormone  or  follicle-stimulating  hormone  were  not  deter-
ined.
The  body  mass  was  measured  (wearing  light  clothes  and
ithout  shoes)  in  a  single  assessment  using  a platform  scale
ilizolaTM (Indústrias  Filizola  S/A,  São  Paulo-SP,  Brazil;  model
L  180),  with  a  capacity  of  180kg  and  an  accuracy  of  100g.
he  stature  was  assessed  using  a  stadiometer  with  a  pre-
ision  of  0.1cm  (Sanny,  São  Bernardo  do  Campo,  SP,  Brazil;
odel  ES  2030).  BMI  values  were  calculated  as  the  quotient
f  body  mass  (kg)  and  the  square  of  the  stature  (m).  For
he  determination  of  WC,  subjects  were  placed  in  a  stand-
ng  position  with  the  abdomen  and  arms  relaxed  alongside
he  body,  and  a  ﬂexible  measuring  tape  (1mm  accuracy)
as  held  horizontally  at  the  midpoint  between  the  bottom
dge  of  the  last  rib  and  the  iliac  crest.  The  measurements
ere  recorded  with  the  tape  applied  ﬁrmly  to  the  skin  but
ithout  compression  of  tissues.  Body  composition  was  mea-
ured  by  air  displacement  plethysmography  in  a BOD  POD
ody  composition  system  (version  1.69;  Life  Measurement
nstruments,  Concord,  CA).
Blood  samples  (10mL)  were  collected  from  overnight
asted  adolescents  by  venous  puncture  and  transferred,
s  appropriate,  to  heparinized  and  non-heparinized  vials.
lasma  glucose  was  determined  with  the  aid  of  a  commer-
ial  kit  and  a  UniCell  DXI  800  spectrophotometer  (Beckman
oulter,  Fullerton,  CA,  USA),  while  speciﬁc  insulin  (without
 peptide)  was  determined  using  an  enzyme  assay  and  an
dvia  2400/Kovalent  analyzer  (Siemens,  São  Paulo,  Brazil).
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erum  levels  of  hepatic  transaminases,  alanine  aminotrans-
erase  (ALT),  and  aspartate  aminotransferase  (AST)  were
nalyzed  using  a  commercial  kit  (CELM,  Barueri,  Brazil).
nsulin  resistance  was  assessed  by  homeostasis  model  assess-
ent  insulin  resistance  index  (HOMA-IR).  HOMA-IR  was
alculated  by  the  fasting  blood  glucose  (FBG)  and  the
mmunoreactive  insulin  (I):  [FBG  (mg/dL)  ×  I  (mU/L)]/405.
Obese  adolescents  were  divided  into  quartiles  accord-
ng  to  WC.  For  the  ﬁrst  quartile,  adolescents  with  WC  less
han  91.8cm  (low  WC);  for  the  second  quartile,  adolescents
ith  WC  values  between  91.8  and  99cm  (moderate  WC);  for
he  third  quartile,  adolescents  with  WC  between  99.1  and
07.5cm  (high  WC);  ﬁnally,  for  the  fourth  quartile,  adoles-
ents  with  WC  above  107.5cm  were  included.
Statistical  analyses  were  performed  using  PASW  Statis-
ics  version  19  (SPSS  Inc,  Chicago,  IL,  USA)  with  the  level  of
igniﬁcance  set  at  p<0.05.  Mean  values  of  the  nutritional
arameters  (age,  height,  weight,  HAZ,  BMI  and  WC)  and
erum  analyses  (insulin,  glucose,  ALT  and  AST)  of  the  non-
AFLD  and  NAFLD  groups,  stratiﬁed  according  to  gender,
ere  compared  using  independent  t-test  and  the  assump-
ions  of  homoscedasticity  veriﬁed  using  the  Levene  test.
earson  correlation  coefﬁcient  was  used  to  determine  the
elationship  between  the  independent  variable  nutritional
tatus  and  biochemical  parameters  and  WC.  Chi  square  test
or  trend  was  used  to  determine  the  relationship  between
he  prevalence  of  the  NAFLD  and  WC  quartile  by  gen-
er.  Lastly,  we  performed  analysis  of  covariance,  using  the
resence  of  NAFLD  as  factor,  and  WC  as  dependent  vari-
ble.  Since  other  anthropometric  variables  presented  a  high
egree  of  correlation  with  WC,  the  confounding  effects  of
ge  and  gender  were  evaluated  in  the  NAFLD  group.
esults
he  study  enrolled  247  obese  adolescents:  90  boys  (36.5%)
nd  157  girls  (63.5%).  Among  the  participants  148  (60%)  pre-
ented  NAFLD.  The  body  composition,  and  anthropometric
nd  biochemical  characteristics  of  the  subjects  are  pre-
ented  in  Table  1.
The  NAFLD  patients  had  signiﬁcantly  higher  values  for
ody  weight,  BAZ-score,  BMI,  total  fat  (%  and  kg),  WC,  vis-
eral  fat,  insulin,  HOMA-IR,  AST  and  ALT,  when  compared
ith  non-NAFLD  obese  adolescents.  It  is  important  to  note
hat  the  mean±standard  error  of  WC  remained  higher  in  the
AFLD  vs  non-NAFLD  group  (107.00±0.83  and  98.85±0.83;
<0.001,  respectively),  even  after  adjustments  for  possible
onfounders.  In  boys  with  NAFLD,  body  weight,  BAZ-score,
MI,  total  fat  (%  and  kg),  WC,  visceral  fat,  insulin,  HOMA-
R,  AST  and  ALT  were  signiﬁcantly  higher  than  the  values
ound  for  non-NAFLD  obese  boys.  In  girls  with  NAFLD,  val-
es  of  body  weight,  BAZ-score,  BMI,  total  fat  (%  and  kg),
C,  visceral  fat,  insulin  and  HOMA-IR  were  higher  than  those
btained  in  non-NAFLD  obese  girls  (Table  1).
In  obese  boys  with  NAFLD,  the  values  of  body  weight,  fat
ree  mass  (%  and  kg),  WC,  visceral  fat,  HOMA-IR,  ASL,  and
LT  are  signiﬁcantly  higher  when  compared  with  girls  of  the
ame  group.  However,  obese  girls  of  NAFLD  group  had  signif-
cantly  more  of  total  fat  (47.71±4.84  vs  42.92±6.08%)  than
bese  boys  with  NAFLD.  Obese  girls  of  group  non-NAFLD  pre-
ented  lower  values  of  body  weight,  fat  free  mass  (%  and  kg),
I
h
a
wigure  2  Prevalence  of  NAFLD  according  to  quartiles  of  waist
ircumference.
C  and  AST  when  compared  with  obese  non-NAFLD  boys,  but
bese  non-NAFLD  girls  had  higher  value  of  total  fat  (%)  than
bese  non-NAFLD  boys  (Table  2).
Differences  between  genders  were  found  according  to
uartiles  of  WC  (Table  2).  In  the  ﬁrst  quartile,  obese
oys  presented  signiﬁcantly  higher  values  of  subcuta-
eous  fat  (3.17±0.82  vs  2.42±0.66)  when  compared  with
bese  girls.  In  the  second  quartile,  higher  values  of  BMI
35.01±3.24  vs  32.67±1.82)  and  total  fat  (46.44±4.79%
s  37.84±5.89%)  were  noted  among  obese  boys  than
mong  obese  girls.  BMI,  total  fat  and  subcutaneous  fat
ere  also  signiﬁcantly  higher  in  obese  boys  when  com-
ared  with  girls  in  the  3rd  quartile  (38.09±4.06kg/m2
s  35.32kg/m2±3.66,  48.70±4.39%  vs  39.16±6.15%  and
.37±1.03cm  vs  3.58±0.68cm,  respectively).  Moreover,  in
he  same  quartile,  higher  values  of  visceral  fat  (4.19±1.52
s  5.07±1.33cm),  AST  (21.43±4.74  vs  30.80±13.90U/L)  and
LT  (26.12±10.42  vs  30.80±13.90U/L)  were  observed  in
bese  girls  when  compared  with  obese  boys.  Finally,  in  the
th  quartile  in  obese  boys  presented  signiﬁcantly  higher  val-
es  in  total  fat  (49.76±4.17%  vs  43.97±5.94%)  and  obese
irls  had  signiﬁcantly  higher  values  of  AST  (21.39±4.42  vs
9.48±10.43U/L)  and  ALT  (25.32±8.60  vs  45.30±26.89U/L).
Correlations  between  WC,  biochemical  and  anthropomet-
ic  parameters  according  to  gender  are  shown  in  Table  3.
n  obese  girls,  the  WC  exhibited  positive  correlations  with
AZ  (r=0.72,  p<0.01),  BMI  (r=0.76,  p=0.01),  total  fat  (%)
r=0.38,  p=0.01),  visceral  fat  (r=0.50;  p=0.01),  subcuta-
eous  fat  (r=0.42;  p=0.01),  HOMA-IR  (r=0.38;  p=0.01),  AST
r=0.26;  p=0.01)  and  ALT  (r=0.32;  p=0.02).  In  obese  boys,
C  positively  correlated  with  BAZ  (r=0.73;  p=0.01),  BMI
r=0.76;  p=0.01),  total  fat  (r=0.58;  p=0.01),  visceral  fat
r=0.30;  p=0.01)  and  subcutaneous  fat  (r=0.47;  p=0.01).
Fig.  2  shows  that  the  prevalence  of  NAFLD  increases  with
he  increase  in  the  quartile  of  WC.
iscussion
herefore,  the  most  important  ﬁnding  of  the  study  was  that
2.4%  and  71.9%  of  girls  and  boys  with  NAFLD,  respectively,
ere  classiﬁed  in  the  highest  quartile  of  WC  (WC>107.5cm).n  agreement,  the  NAFLD  adolescents  had  signiﬁcantly
igher  values  for  body  weight,  BAZ-score,  BMI,  total  fat  (%
nd  kg),  WC,  visceral  fat,  insulin,  HOMA-IR,  AST  and  ALT,
hen  compared  with  non-NAFLD  obese  adolescents.
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Table  1  Anthropometric,  body  composition  and  biochemical  parameters  of  the  studied  population.
NAFLD
(n=40)
Non-NAFLD
(n=50)
NAFLD
(n=59)
Non-NAFLD
(n=98
NAFLD
(n=148)
Non-NAFLD
(n=99)
p-value
Boys
p-value
Girls
Gender
Groupa
Gender
Groupb
Total
Age  (years) 16.78±1.63 15.87±1.65 16.94±2.10 16.30±1.80 16.88±1.92 16.15±1.76 0.01 0.04 0.67 0.15 0.02
Weight  (kg) 117.07±17.24 100.48±16.08 100.69±15.45 91.13±13.75 107.31±18.02 94.29±15.19 <0.01 <0.01 <0.01 <0.01 <0.01
Height  (cm) 174.65±6.77 171.34±8.18 163.37±6.85 162.53±5.93 167.92±8.77 165.50±7.93 0.04 0.41 <0.01 <0.01 0.03
BAZ  (Z  score) 3.51±0.83 3.04±0.65 3.25±0.80 2.82±0.69 3.36±0.82 2.89±0.68 0.04 0.01 0.07 0.23 <0.01
BMI  (kg/m2) 38.37±4.95 34.08±4.10 37.71±4.98 34.46±4.52 37.97±4.95 34.33±4.38 <0.01 <0.01 0.52 0.64 <0.01
Total  fat  (%) 42.92±6.08 38.08±6.04 47.71±4.84 45.20±5.54 45.77±5.84 42.97±6.49 0.01 0.05 <0.01 <0.01 0.01
Fat  free  mass  (%) 57.32±5.98 61.50±6.18 52.28±4.84 54.92±5.43 54.32±5.85 57.16±6.48 0.02 0.03 <0.01 <0.01  0.01
Total fat  (kg) 50.72±12.25 38.96±9.96 48.35±10.47 41.37±10.28 49.31±11.22 40.55±10.20 <0.01 <0.01 0.31 0.17  <0.01
Fat free  mass  (kg) 66.52±9.76 62.58±10.95 52.28±6.97 49.31±5.02 58.04±10.77 53.82±9.83 0.08 0.05 <0.01  <0.01  0.02
WC (cm) 110.30±10.83 99.34±8.17 102.59±10.82 94.71±9.05 105.70±11.42 96.27±9.01 <0.01 <0.01 0.01 0.03 <0.01
Visceral  fat  (cm) 5.82±1.64 4.30±1.23 4.52±1.31 3.73±1.20 5.05±1.58 3.92±1.24 <0.01 <0.01 <0.01 0.22 <0.01
Subcutaneous  fat  (cm) 3.60±0.95 3.44±0.88 3.86±1.09 3.69±1.04 3.75±1.04 3.60±1.00 0.41 0.33 0.27 0.07 0.26
Glucose  (mg/dL) 92.17±7.99 91.54±6.47 89.91±7.52 89.93±6.58 90.82±7.75 90.47±6.56 0.68 0.98 0.15 0.16 0.70
Insulin  (uU/mL) 23.87±12.42 15.98±10.28 20.00±8.33 16.10±10.37 21.56±10.30 16.06±10.30 <0.01 0.01 0.06 0.95 <0.01
HOMA-IR  5.47±2.91 3.64±2.51 4.37±1.90 3.66±2.94 4.81±2.41 3.65±2.79 0.02 0.01 0.04 0.98 0.01
AST,  U/L 32.30±14.00 24.36±6.23 22.08±4.88 21.77±6.31 26.21±10.84 22.64±6.38 0.02 0.74 <0.01 0.02 0.01
ALT,  U/L 50.42±17.03 28.74±15.04 26.81±10.63 24.46±12.01 36.35±16.28 25.91±13.22 0.01 0.21 <0.01 0.06 <0.01
BMI, body mass index; BAZ, BMI-for-age; AST, aspartate aminotransferase; ALT, alanine aminotransferase; WC, waist circumference.
a Comparison of the gender with NAFLD.
b Comparison of the gender with Non-NAFLD.
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Table  2  Anthropometric,  subcutaneous  and  visceral  adipose  tissues,  HOMA-IR  and  liver  enzymes  in  obese  adolescents  according  quartiles  of  waist  circumference  expressed
as mean±standard  deviation.
Low:  1st  (<91.8cm)  Moderate:  2nd  (≥91.8--99cm)  High:  3rd  (>99--107.5cm)  Very  High:  4th  (>107.5cm)
Boys  (n=51)  Girls  (n=11)  Boys  (n=45)  Girls  (n=17)  Boys  (n=32)  Girls  (n=30)  Boys  (n=28)  Girls  (n=33)
BAZ  (Z
score)
2.49±0.31  2.66±0.29  2.86±0.46  2.73±0.28  3.29±0.58  3.09±0.54  3.77±0.61  3.82±0.61
BMI (kg/m2)  31.49±2.41  30.54±2.71  35.01±3.24  32.67±1.82a 38.09±4.06  35.32±3.66a 41.46±4.19  40.15±4.11
Total fat  (%)  39.10±6.07  42.17±4.53  46.44±4.79  37.84±5.89a 48.70±4.39  39.16±6.15a 49.76±4.17  43.97±5.94a
WC  (cm)  86.54±3.88  87.42±3.77  95.81±2.30  95.50±2.53  103.65±2.54  102.67±1.88  113.60±6.23  115.57±6.59
Visceral fat
(cm)
3.48±1.12  3.96±1.17  4.06±1.06  3.76±1.15  4.19±1.52  5.07±1.33a 4.69±1.20  5.75±1.71
Subcutaneous
fat (cm)
3.17±0.82  2.42±0.66a 3.66±0.72  3.44±0.83  4.37±1.03  3.58±0.68a 4.38±1.22  3.85±1.02
HOMA-IR 3.82±1.75  3.31±1.95  3.49±1.44  4.02±2.78  4.01±1.68  4.16±1.69  4.75±1.88  5.31±3.14
AST U/L  22.88±7.54  20.81±3.02  21.06±4.42  24.76±7.07  21.43±4.74  30.80±13.90a 21.39±4.42  29.48±10.43a
ALT  U/L  25.50±14.30  19.27±6.72  24.08±10.08  29.58±13.22  26.12±10.42  30.80±13.90a 25.32±8.60  45.30±12.89a
AST, aspartate aminotransferase; ALT, alanine aminotransferase; WC, waist circumference.
a Difference of the genders at the same quartile.
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Table  3  Correlations  between  waist  circumference,  biochemical  and  anthropometric  parameters.
Girls  (n=157)  Boys  (n=90)
Pearson  R p-value Pearson  R p-value
BAZ  (Z  score)  0.722  0.001  0.731  0.001
BMI (kg/m2)  0.759  0.001  0.760  0.001
Total fat  (%)  0.382  0.001  0.581  0.001
Visceral fat  (cm)  0.504  0.001  0.306  0.001
Subcutaneous  fat  (cm)  0.424  0.001  0.470  0.001
HOMA-IR 0.384  0.001  0.128  0.111
AST, U/L 0.259 0.013 −0.041 0.610
ALT,  U/L 0.324 0.002 0.109 0.615
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sAST, aspartate aminotransferase; ALT, alanine aminotransferase.
Corroborating  with  these  results,  it  has  been  previously
shown  that  both  insulin  resistance  and  abdominal  adipose
tissue  are  key  risk  factors  to  the  development  of  NAFLD.
Hepatic  cirrhosis  may  be  a  consequence  of  the  NAFLD  in
long-term  and  this  may  result  in  a  higher  risk  of  liver  disease-
related  mortality,  reinforcing  the  importance  of  the  present
investigation.4,8,17,18
Moreover,  it  is  well  known  that  individuals  with  increased
abdominal  fat  are  more  susceptible  to  metabolic  disorders,
which  are  developed  during  childhood.19,20 In  fact,  in  this
study  insulin  resistance  was  higher  in  the  3rd  and  4th  quar-
tiles  when  compared  with  the  1st  quartile  of  WC  in  obese
adolescents.
Furthermore,  studies  in  adults  have  found  that  high
levels  of  hepatic  enzymes,  particularly  ALT,  could  predict
insulin  resistance  and  later  development  of  type  2  dia-
betes  mellitus.  Other  studies  highlight  that  ALT  seems  to
be  an  important  marker  of  fatty  liver  disease  in  pediatric
population.21--23 In  our  study,  girls  had  signiﬁcantly  higher
values  of  ALT  in  the  3rd  and  4th  quartile  of  WC  when  com-
pared  with  boys.  In  the  literature,  another  study  showed
the  opposite:  obese  boys  with  NAFLD  had  higher  ALT  val-
ues  than  obese  girls.24 Therefore,  large  cohort  studies  are
needed  to  deﬁne  gender  differences  in  ALT  in  obese  ado-
lescents.  Despite  the  controversy,  the  results  suggest  that
sex  hormones  have  a  role  in  the  manifestation  of  insulin
resistance,  beyond  distribution  of  fat,  muscle  and  binding
globulin  produced  in  the  liver,  which  are  strongly  corre-
lated  with  insulin  sensitivity  and  the  differences  between
ALT  serum  concentrations  by  gender.24
Importantly,  it  has  been  showed  that  abdominal  obe-
sity  and  NAFLD  are  strongly  associated  with  cardiovascular
disease.9,13,25 Also,  previous  research  showed  that  visceral
adiposity  was  closely  related  to  NAFLD.8 In  this  way,  both
BMI  and  WC  have  been  considered  as  predictors  of  NAFLD
severity  and  independent  predictors  of  steatosis.25Although
biopsy  is  the  gold  standard  technique  for  the  diagnosis  of
NAFLD,  this  method  is  invasive  and  difﬁcult  to  apply  in
clinical  practice,  especially  in  the  pediatric  population.26
Additionally,  ultrasound  imaging  and  magnetic  resonance
for  diagnosis  of  NAFLD  have  some  limitations,  such  as  the
high  cost  to  be  used  as  a  screening  method  in  developing
countries.  Thus,  it  is  imperative  to  develop  simple  and  sen-
sitivity  indicators  to  identify  NAFLD.13,14
d
t
pRecently,  WC  has  been  considered  as  a  potential
creening  tool  for  liver  steatosis  and  cardiovascular  risk,
eing  the  most  cost-effective  and  feasible  replacement  for
ltrasound  and  magnetic  resonance  in  the  assessment  of
AFLD  in  obese  adolescents.27 Our  results  reinforce  this  ﬁnd-
ng,  suggesting  that  WC  >99cm  (3rd  quartile)  as  a  cutoff
or  detection  of  NAFLD  and  metabolic  alterations.  In  addi-
ion,  we  demonstrated  that  the  obese  adolescents  in  the
rd  and  4th  quartiles  of  WC  presented  higher  prevalence
f  NAFLD  when  compared  with  those  on  the  1st  quartile,
or  both  genders.  These  results  show  the  importance  of  this
nthropometric  measurement  to  detect  incremental  risk  of
teatosis  in  the  analyzed  population.
Together  these  results  reinforce  that  WC  is  simple  to
easure  and  can  be  applied  as  an  important  anthropo-
etric  indicator  of  central  obesity  to  screen  adolescents
ith  high  risk  for  NAFLD.  The  measure  of  WC  is  considered
 new  risk  factor  for  metabolic  syndrome,  with  advan-
ages  for  the  diagnosis  and  follow-up  of  the  treatment  in
AFLD  patients.28 Although,  more  researches  with  differ-
nt  populations  are  needed  to  conﬁrm  the  external  validity
f  the  obtained  results,  this  study  suggests  that  the  use
f  such  a  marker  in  clinical  practice  could  be  valuable
ince  anthropometrical  measurements  are  inexpensive  and
traightforward.11
The  criteria  for  diagnosis  of  metabolic  syndrome  in  ado-
escents  adopted  from  the  International  Diabetes  Federation
IDF)  considers  WC  greater  than  80cm  for  girls  and  94cm  for
oys  have  high  sensitivity  for  screening  adolescents  at  risk
f  metabolic  disorders.12 Another  study  with  adults  showed
hat  appropriate  cutoff  points  of  WC  for  detecting  NAFLD
ere  89cm  for  men  and  84cm  for  women  with  high  neg-
tive  predictive  values  for  NAFLD.29 These  results  conﬁrm
he  importance  of  using  WC  in  clinical  practice,  as  it  may
ontribute  to  evaluate  the  risk  of  NAFLD  and  insulin  resis-
ance.  In  this  way,  the  identiﬁcation  of  threshold  values
or  WC  in  children  and  adolescents  is  a  crucial  component
n  developing  a  strategy  for  the  prevention  of  metabolic
iseases  as  NAFLD  in  overweight  subjects.  Therefore,  the
ajor  ﬁnding  of  this  study  is  that  WC  is  a  convenient  mea-
ure  of  abdominal  obesity  associated  with  the  risk  of  NAFLD
evelopment  in  obese  adolescents.  This  tool  requires  only
he  purchase  of  an  appropriate  tape  measure  and  sim-
le  training  of  health  professionals  and/or  assistants.  It
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24  
an  be  easily  incorporated  in  the  assessment  of  children
nd  adolescents  at  the  time  the  body  weight  is  obtained.
he  implementation  of  preventive  measures  among  vulner-
ble  populations  would  ensure  a  better  quality  of  life  and
ould  serve  to  minimize  future  spending  by  health  care
ystems.
There  are  some  limitations  to  this  study.  Because  of  its
ross  sectional  design,  our  study  does  not  provide  evidence
f  a  cause  and  effect  relationship.  WC  values  proposed  in
his  study  cannot  be  generalized  to  other  populations,  more
esearches  with  different  populations  are  needed  to  conﬁrm
he  external  validity  of  the  obtained  results.  Despite  these
imitations,  our  research  indicates  that  higher  WC  may  be  a
igniﬁcant  risk  factor  for  the  development  of  metabolic  dis-
rders.  In  particular,  the  values  of  WC  found  in  the  3rd  and
th  quartiles  for  girls  and  boys  might  be  a  reliable  screening
ool  for  NAFLD  risk  in  obese  adolescents.  The  present  ﬁnd-
ngs  suggest  the  need  for  further  longitudinal  studies,  with
arger  samples,  from  different  geographical/socio-cultural
nvironments.  In  conclusion,  the  results  presented  here  sug-
est  that  an  increase  in  WC  can  reliably  predict  the  risk  of
AFLD  in  obese  adolescents.  This  is  a  low  cost  and  easy-to-
se  tool  that  can  help  in  screening  metabolic  risk  factors  in
dolescents.
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